Healthcare Services

Global Blood Plasma Derivatives Market Anticipated To Grow To $86.67 Billion By 2030 At 9.3% CAGR

May 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Blood Plasma Derivatives Market Become By 2030 Compared To 2026?

The blood platelets market size has experienced significant expansion over recent years. It is forecast to grow from $6.7 billion in 2025 to $7.17 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. The growth observed in the past can be attributed to increasing surgical procedures, the expansion of trauma care facilities, a rising demand for platelet transfusions, the growth in oncology treatments, and improvements in blood collection infrastructure.

The blood platelets market size is set for substantial expansion in the coming years. It is projected to climb to $9.28 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.7%. This anticipated growth is influenced by the increasing occurrence of thrombocytopenia cases, a rising need from cancer treatment facilities, the broadening of advanced transfusion services, an intensified focus on transfusion safety, and investments in next-generation platelet storage technologies. Significant trends for the forecast period encompass the expanded utilization of apheresis-derived platelets, a greater adoption of pathogen-reduced platelet products, the growth of automated platelet collection systems, a growing emphasis on extending platelet shelf-life, and enhanced oversight of platelet quality.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

Which Major Factors Are Contributing To The Development Of The Blood Plasma Derivatives Market?

The future expansion of the blood platelets market is anticipated to be driven by the growing incidence of blood disorders. These conditions, which involve impairments in the function, production, or constituents of blood such as red blood cells, white blood cells, platelets, or plasma, can result in problems like anemia, clotting abnormalities, or compromised immune systems. The escalating occurrence of blood disorders is largely attributed to the aging demographic, as advanced age often diminishes bone marrow function, thereby elevating older adults’ susceptibility to ailments including anemia, thrombocytopenia, and various clotting disorders. Blood platelets play a crucial role in treating blood disorders by managing blood clotting, thus becoming vital for averting excessive hemorrhage and facilitating wound recovery. For instance, in October 2025, according to the World Federation of Hemophilia (WFH) Annual Global Survey (AGS) In 2024, the data reveals a 6% rise in the global identification of individuals with hemophilia, a 6% rise in those identified with VWD, and a 9% rise in the detection of other inherited bleeding disorders. Consequently, the rising prevalence of blood disorders is a key factor propelling the growth of the blood platelets market.

What Segment Types Are Included In The Blood Plasma Derivatives Market Analysis?

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

Which Trends Are Supporting The Evolution Of The Blood Plasma Derivatives Market?

Major companies in the blood platelet market are concentrating on developing creative solutions, like platelet pooling, to prolong shelf life, improve availability, and help blood centers meet rising transfusion needs. Platelet pooling is the process of combining platelets from several whole blood donations to produce a single platelet unit for transfusion, thereby enhancing availability, efficiency, and resource usage in managing blood supply. For example, in February 2023, the US-based medical technology company Terumo Blood and Cell Technologies introduced the IMUGARD WB platelet pooling set after securing clearance from the U.S. Food and Drug Administration (FDA). This innovation extends the shelf life of whole blood-derived platelets from five to seven days, increasing platelet availability for transfusions. It also offers an alternative platelet supply source to address growing demand and donor shortages, assisting blood centers in optimizing inventory management and reducing waste.

Who Are The Major Companies Operating In The Blood Plasma Derivatives Market?

Major companies operating in the blood plasma derivatives market are Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

Access The Complete Blood Plasma Derivatives Market Report:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Which Region Contributes The Most To The Blood Plasma Derivatives Market?

North America was the largest region in the blood plasma derivatives market in 2025. The regions covered in the blood plasma derivatives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Blood Plasma Derivatives Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

Browse Through More Reports Similar to the Global Blood Plasma Derivatives Market 2026, By The Business Research Company

Therapeutic Plasma Exchange Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Plasma Protein Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Plasma Powder Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-powder-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795